Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinbao pill for chronic heart failure with heart-kidney yang deficiency syndrome
ChiCTR2000038492Phase 4Recruiting
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xinbao Pill in chronic heart failure (CHF) (2 arms), sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Proportion of patients with serum NT-proBNP decrease greater than 30%. Started Nov 2020; status: recruiting.
02
Drugs
Xinbao Pill
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR2000038492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038492.